Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|January 13, 2025
CEBPA repression by MECOM blocks differentiation to drive aggressive leukemiasTravis J Fleming, Mateusz Antoszewski, Sander Lambo, et al.
Cancer Medicine|June 2, 2023
A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumorsRaja Shaikh, Brent R Weil, Christopher B Weldon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignanciesDavid S Shulman, Kieuhoa T Vo, Frank M Balis, et al.
Blood|September 24, 2025
CEBPA repression by MECOM blocks differentiation to drive aggressive leukemiasTravis J Fleming, Mateusz Antoszewski, Sander Lambo, et al.
Blood|December 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AMLWallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, et al.
Nature Cancer|May 9, 2022
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemiaBrandon J Aubrey, Jevon A Cutler, Wallace Bourgeois, et al.
Developmental Cell|June 1, 2024
Nucleotide depletion promotes cell fate transitions by inducing DNA replication stressBrian T Do, Peggy P Hsu, Sidney Y Vermeulen, et al.
Cell Reports|April 27, 2022
Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cellsVivian Morris, Dahai Wang, Zhiheng Li, et al.
Science Translational Medicine|March 9, 2018
Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemiaFlorence F Wagner, Lina Benajiba, Arthur J Campbell, et al.
Pediatric Blood & Cancer|October 7, 2020
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001Melissa A Burns, Andrew E Place, Kristen E Stevenson, et al.
Pageof 6